Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

BACKGROUND: The current use of targeted therapy plus neoadjuvant chemotherapy for inflammatory breast cancer (IBC) is based on data extrapolated from studies in non-IBC. We conducted a systematic review to determine whether neoadjuvant chemotherapy plus targeted therapy results in a higher pathologi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Chainitikun, Sudpreeda, Espinosa Fernandez, Jose Rodrigo, Long, James P., Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8051801/
https://ncbi.nlm.nih.gov/pubmed/33861773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0250057
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge